Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01309659 · ClinicalTrials.gov registry record · Phase 2
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
A Phase 2 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 19
- Enrollment target
NCT01309659 is a Phase 2 study that was terminated before completion, run by Duke University. The registered enrollment target is 19 participants.
The verdict
NCT01309659, a Phase 2 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether treatment of unexplained anemia in older adults with a short course of weekly intravenous iron infusions can improve physical activity and therefore quality of life.
Interventions
- DRUG iron sucrose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2011-05 |
| Est. Completion | 2014-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01309659
The ClinicalTrials.gov registry entry for NCT01309659 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iron sucrose is the first listed.
NCT01309659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01309659 about?
NCT01309659 is a clinical study titled "Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia". The purpose of this study is to determine whether treatment of unexplained anemia in older adults with a short course of weekly intravenous iron infusions can improve physical activity and therefore quality of life.
What is the current status of trial NCT01309659?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 19 participants. The study started on 2011-05. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01309659?
The interventions under investigation include: iron sucrose (DRUG).
Who is sponsoring clinical trial NCT01309659?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.